Loading company…
Uppsala proteomics company offering the Proximity Extension Assay platform for high-throughput protein biomarker analysis.
Founded in 2004 and headquartered in Uppsala, Sweden, Olink Proteomics AB sells proteomics products built on its Proximity Extension Assay technology for multiplex biomarker analysis in discovery and drug development. Its products include Olink Target, Olink Focus and Olink Reveal, sold mainly to academic researchers and pharmaceutical companies. It reported 2022 revenue of USD 134.68 mn and EBITDA of USD 2.42 mn. Its most recent round, on January 18, 2023, raised USD 116.6 mn.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in